Composition and Diversity of Bacterial Community on the Ocular Surface of Patients With Meibomian Gland Dysfunction

From BugSigDB
Needs review
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Dong X, Wang Y, Wang W, Lin P, Huang Y
Journal
Investigative ophthalmology & visual science
Year
2019
PURPOSE: To investigate the composition and diversity of bacterial community on the ocular surface of patients with meibomian gland dysfunction (MGD) via 16S rDNA sequencing. METHODS: Forty-seven patients with MGD, who were divided into groups of mild, moderate, and severe MGD, and 42 sex- and age-matched participants without MGD (control group) were enrolled. Samples were collected from the upper and lower conjunctival sac of one randomly chosen eye of each participant. Through sequencing the hypervariable region of 16S rDNA gene obtained from samples, differences in the taxonomy and diversity between groups were compared. RESULTS: Principle coordinate analysis showed significantly distinct clustering of the conjunctival sac bacterial community between the severe MGD group and the other groups. At the phylum level, the relative abundances of Firmicutes (31.70% vs. 19.67%) and Proteobacteria (27.46% vs. 14.66%) were significantly higher (P < 0.05, Mann-Whitney U), and the abundance of Actinobacteria (34.17% vs. 56.98%) was lower in MGD than controls (P < 0.05, Mann-Whitney U). At the genus level, the abundances of Staphylococcus (20.71% vs. 7.88%) and Sphingomonas (5.73% vs. 0.79%) in patients with MGD were significantly higher than the controls (P < 0.05, Mann-Whitney U), while the abundance of Corynebacterium (20.22% vs. 46.43%) was significantly lower (P < 0.05, Mann-Whitney U). The abundance of Staphylococcus was positively correlated with the meiboscores in patients with MGD (r = 0.650, P < 0.001, Spearman). CONCLUSIONS: Patients with MGD can have various degrees of bacterial microbiota imbalance in the conjunctival sac. Staphylococcus, Corynebacterium, and Sphingomonas may play roles in the pathophysiology of MGD.

Experiment 1


Needs review

Curated date: 2023/10/16

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland, Davvve, LGeistlinger

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Margin of eyelid , Conjunctival sac Free margin of eyelid,Margin of eyelid,Conjunctiva serous sac,Subbrillar sac,Conjunctival sac
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
dry eye syndrome dry eye,Dry Eye Syndrome,dry eye syndrome,Dry Eye Syndromes,dry eye(s),eye(s), dry,KCS,Keraconjunctivitis sicca,Keratoconjunctivitis Sicca,Keratoconjunctivitis sicca,keratoconjunctivitis sicca,Keratoconjunctivitis sicca (disorder),sicca, keratoconjunctivitis,Tear film insufficiency,tear film insufficiency
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Meibomian Gland Dysfunction (MGD)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with mild, moderate of severe diagnosis of MGD
Group 0 sample size Number of subjects in the control (unexposed) group
42
Group 1 sample size Number of subjects in the case (exposed) group
47
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
2 weeks

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Needs review

Curated date: 2023/10/16

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland

Source: Fig 2a and 2b

Description: FIGURE 2. The relative abundances of dominant phyla and genera in the patients with MGD and the controls. (A) The relative abundances of top 5 most abundant phyla. Compared with the control group, the patients with MGD had significantly higher abundances of Firmicutes, Proteobacteria, and Deinococcus-Thermus, and a significantly lower abundance of Actinobacteria. (B) The relative abundances of top 6 most abundant genera. Compared with the control group, the patients with MGD had significantly higher abundances of Staphylococcus and Sphingomonas, and a significantly lower abundance of Corynebacterium (*P < 0.05, **P < 0.01, ***P < 0.001).

Abundance in Group 1: increased abundance in Meibomian Gland Dysfunction (MGD)

NCBI Quality ControlLinks
Bacillota
Deinococcota
Pseudomonadota
Sphingomonas
Staphylococcus

Revision editor(s): Mary Bearkland

Signature 2

Needs review

Curated date: 2023/10/16

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland

Source: Fig 2a and 2b

Description: FIGURE 2. The relative abundances of dominant phyla and genera in the patients with MGD and the controls. (A) The relative abundances of top 5 most abundant phyla. Compared with the control group, the patients with MGD had significantly higher abundances of Firmicutes, Proteobacteria, and Deinococcus-Thermus, and a significantly lower abundance of Actinobacteria. (B) The relative abundances of top 6 most abundant genera. Compared with the control group, the patients with MGD had significantly higher abundances of Staphylococcus and Sphingomonas, and a significantly lower abundance of Corynebacterium (*P < 0.05, **P < 0.01, ***P < 0.001).

Abundance in Group 1: decreased abundance in Meibomian Gland Dysfunction (MGD)

NCBI Quality ControlLinks
Actinomycetales
Corynebacterium

Revision editor(s): Mary Bearkland

Experiment 2


Needs review

Curated date: 2023/10/16

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland, Davvve, LGeistlinger

Differences from previous experiment shown

Subjects

Lab analysis

Statistical Analysis

Statistical test
LEfSe
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
4

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Needs review

Curated date: 2023/10/16

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland, Chikamso

Source: Fig 3b

Description: Linear discriminant analysis scoring

< of biomarkers corresponding to (A), computed by the LEfSe tool. When the score of a taxon was >4.0 with P 0.01, it was listed in the histogram, which showed all the biomarkers found from the domain to species level. ‘‘p’’, ‘‘c’’, ‘‘o’’, ‘‘f ’’, ‘‘g’’, and ‘‘s’’ referred to phylum, class, order, family, genus, and species, respectively. At the genus level, the biomarkers were Staphylococcus and Sphingomonas in the patients with MGD, and Corynebacterium in the controls. The length of the histogram represented the linear discriminate analysis values of the different taxa.

Abundance in Group 1: increased abundance in Meibomian Gland Dysfunction (MGD)

NCBI Quality ControlLinks
Alphaproteobacteria
Bacillales
Bacilli
Gammaproteobacteria
Pseudomonadota
Sphingomonadaceae
Sphingomonadales
Sphingomonas
Sphingomonas melonis
Staphylococcaceae
Staphylococcus
Staphylococcus epidermidis
Bacillota

Revision editor(s): Mary Bearkland, Chikamso

Signature 2

Needs review

Curated date: 2023/10/16

Curator: Mary Bearkland

Revision editor(s): Mary Bearkland, Chikamso

Source: Figure 3

Description: Linear discriminant analysis scoring

< of biomarkers corresponding to (A), computed by the LEfSe tool. When the score of a taxon was >4.0 with P 0.01, it was listed in the histogram, which showed all the biomarkers found from the domain to species level. ‘‘p’’, ‘‘c’’, ‘‘o’’, ‘‘f ’’, ‘‘g’’, and ‘‘s’’ referred to phylum, class, order, family, genus, and species, respectively. At the genus level, the biomarkers were Staphylococcus and Sphingomonas in the patients with MGD, and Corynebacterium in the controls. The length of the histogram represented the linear discriminate analysis values of the different taxa.

Abundance in Group 1: decreased abundance in Meibomian Gland Dysfunction (MGD)

NCBI Quality ControlLinks
Actinomycetales
Actinomycetota
Corynebacteriaceae
Corynebacterium
Corynebacterium sp.
Actinomycetes

Revision editor(s): Mary Bearkland, Chikamso